Publication | Closed Access
US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection
12
Citations
13
References
2017
Year
HepatologyHepatitis CViral HepatitisElbasvir/grazoprevir TreatmentAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyChronic Viral InfectionAntiviral DrugUs Fda PerspectiveMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1